Skip to main content

Case Search

40394 Aspen

Economic Activity: C.21.2 - Manufacture of pharmaceutical preparations
Events:
Date Document Type Document
03.05.2021 Trustee contact details en pdf  Published on 03.05.2021
10.02.2021 Commitments Decision en pdf  Published on 15.04.2021
10.02.2021 Press Release Commission accepts commitments by Aspen to reduce prices for six off-patent cancer medicines by 73% addressing excessive pricing concerns:
Multilingual
10.02.2021 Final commitments en pdf  Published on 10.02.2021
15.07.2020 Market Test Notice (Art. 27(4)) Market Test Notice (Art. 27(4)):
Multilingual
14.07.2020 Memo Antitrust: Aspen proposes 73% price reduction for six off-patent cancer medicines to remove Commission's excessive pricing concerns-Fact sheet:
Multilingual
14.07.2020 Press Release Anitrust: Commission seeks feedback on commitments offered by Aspen to reduce prices for six off-patent cancer medicines by 73% to address Commission’s concerns over excessive pricing:
Multilingual
14.07.2020 Proposed Commitments en pdf  Published on 14.07.2020
15.05.2017 Opening of Proceedings en pdf  Published on 31.05.2017
15.05.2017 Press Release Commission opens formal investigation into Aspen Pharma's pricing practices for cancer medicines:
en
These publications are for information purposes only and should not be considered as an official publication

New Search